Publications
Detailed Information
Diethylnitrosamine (DEN) induces irreversible hepatocellular carcinogenesis through overexpression of G(1)/S-phase regulatory proteins in rat
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Dae-Hun | - |
dc.contributor.author | Shin, Jae Wook | - |
dc.contributor.author | Park, Seung-Kee | - |
dc.contributor.author | Seo, Jae-Nam | - |
dc.contributor.author | Jang, Ja-June | - |
dc.contributor.author | Lee, Min-Jae | - |
dc.contributor.author | Li, Lan | - |
dc.date.accessioned | 2012-05-30T02:37:57Z | - |
dc.date.available | 2012-05-30T02:37:57Z | - |
dc.date.issued | 2009-12-15 | - |
dc.identifier.citation | TOXICOLOGY LETTERS; Vol.191; 321-326 | ko_KR |
dc.identifier.issn | 0378-4274 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76612 | - |
dc.description.abstract | Hepatocellular carcinoma (HCC) is the fifth most frequent cause of cancer deaths in males and was the third most frequent cause of cancer deaths in 2007 throughout the world. The incidence rate is 2-3 times higher in developing countries than in developed countries. Animal models have enabled study of the mechanism of HCC and the development of possible strategies for treatment. Diethylnitrosamine (DEN) is a representative chemical carcinogen with the potential to cause tumors in various organs, including the liver, skin, gastrointestinal tract, and respiratory system Specifically in HCC, DEN is a complete carcinogen. Many lines of evidence have demonstrated a relationship between carcinogenesis and cell cycle regulation. In this study we found that cell cycle regulatory proteins were critically involved in cancer initiation and promotion by DEN. Cyclin D1. cyclin E, cdk4. and p21(CIP1/WAF1) I are factors whose expression levels may be useful as criteria for the classification of hepatic disease. In particular, cdk4 had a pivotal role in the transition to the neoplastic stage. In conclusion. we suggest that changes in the level of cdk4 may be useful as a biomarker for detection of HCC. (C) 2009 Elsevier Ireland Ltd. All rights reserved | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | ELSEVIER IRELAND LTD | ko_KR |
dc.subject | Diethylnitrosamine (DEN) | ko_KR |
dc.subject | Irreversible hepatocelluar carcinogenesis | ko_KR |
dc.subject | G(1)/S phase regulatory protein | ko_KR |
dc.subject | cdk4 | ko_KR |
dc.title | Diethylnitrosamine (DEN) induces irreversible hepatocellular carcinogenesis through overexpression of G(1)/S-phase regulatory proteins in rat | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 박대훈 | - |
dc.contributor.AlternativeAuthor | 신재욱 | - |
dc.contributor.AlternativeAuthor | 박승기 | - |
dc.contributor.AlternativeAuthor | 서재남 | - |
dc.contributor.AlternativeAuthor | 이란 | - |
dc.contributor.AlternativeAuthor | 장자준 | - |
dc.contributor.AlternativeAuthor | 이민재 | - |
dc.identifier.doi | 10.1016/j.toxlet.2009.09.016 | - |
dc.citation.journaltitle | TOXICOLOGY LETTERS | - |
dc.description.citedreference | Chang JJ, 2008, MOL CELL TOXICOL, V4, P278 | - |
dc.description.citedreference | Sell S, 2008, TUMOR BIOL, V29, P161, DOI 10.1159/000143402 | - |
dc.description.citedreference | *AM CANC SOC, 2007, GLOB CAN FACTS FIG 2 | - |
dc.description.citedreference | Kim MR, 2005, EXP MOL MED, V37, P335 | - |
dc.description.citedreference | LI X, 2005, HEPATOB PANCREAT DIS, V4, P427 | - |
dc.description.citedreference | Masaki T, 2003, HEPATOLOGY, V37, P534, DOI 10.1053/jhep.2003.50112 | - |
dc.description.citedreference | Pascale RM, 2002, HEPATOLOGY, V35, P1341, DOI 10.1053/jhep.2002.33682 | - |
dc.description.citedreference | Masaki T, 2000, HEPATOLOGY, V32, P711, DOI 10.1053/jhep.2000.17705 | - |
dc.description.citedreference | Perez-Roger I, 1999, EMBO J, V18, P5310 | - |
dc.description.citedreference | Johnson PJ, 1999, J GASTROEN HEPATOL, V14, pS32 | - |
dc.description.citedreference | Verna L, 1996, PHARMACOL THERAPEUT, V71, P57 | - |
dc.description.citedreference | SHERR CJ, 1994, CELL, V79, P551 | - |
dc.description.citedreference | HUNTER T, 1994, CELL, V79, P573 | - |
dc.description.citedreference | HUNTER T, 1991, CELL, V66, P1071 | - |
dc.description.citedreference | PITOT HC, 1991, ENVIRON HEALTH PERSP, V93, P181 | - |
dc.description.citedreference | DRAGAN YP, 1991, PREV MED, V20, P15 | - |
dc.description.citedreference | XU YH, 1990, CANCER RES, V50, P472 | - |
dc.description.citedreference | BEER DG, 1987, ARCH TOXICOL S, V10, P68 | - |
dc.description.citedreference | RAO MS, 1986, CANCER RES, V46, P5287 | - |
dc.description.citedreference | FARBER E, 1984, CANCER RES, V44, P4217 | - |
dc.description.citedreference | WARD JM, 1981, VIRCHOWS ARCH A, V390, P339 | - |
dc.description.citedreference | COHEN AH, 1976, J CLIN PATHOL, V65, P631 | - |
dc.description.citedreference | ANDERSEN P, 1976, CLIN EXP IMMUNOL, V26, P57 | - |
dc.description.tc | 5 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.